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Studies have found that age and education were associated with cognition in older adults. However,
little is known how clinical factors (e.g. age of illness onset, length of hospital stay, type of anti-
psychotic medications, and duration of illness) are associated with cognitive functioning in patients
with schizophrenia. This study aimed to examine the inﬂuence of socio-demographic and clinical
factors on cognitive domains measured using Mini-Mental State Examination (MMSE) among patients
with schizophrenia or schizoaffective disorders residing in a psychiatric institute in Singapore. A sin-
gle-phase interview was conducted at the Institute of Mental Health (IMH) in patients diagnosed with
schizophrenia or schizoaffective disorders (n¼110). MMSE was administered to all participants. Data
on socio-demographic characteristics, smoking, alcohol consumption, and medical history were col-
lected. Age, gender, and level of education were signiﬁcantly associated with MMSE scores. After ad-
justing for all socio-demographic correlates, longer length of hospital stay remained signiﬁcant in
predicting lower MMSE scores. Length of hospital stay was independently associated with cognitive
functioning. Early interventions for cognition such as physical and mental exercises should be im-
plemented for better prognosis.
& 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cognitive impairment is one of the key problems in patients
with schizophrenia. Studies have found that patients with schi-
zophrenia have more cognitive deﬁcits than healthy individuals
even in the early stages of psychotic illness (Addington et al.,
2005; Keefe and Harvey, 2012). Magnetic resonance imaging
(MRI) studies have found signiﬁcant decrease in cerebral grey
matter volume, cortical volume, and thickness in patients with
schizophrenia than healthy controls participants (Kubota et al.,
2015) and postulated that these could lead to the cognitive de-
cline (Mitelman et al., 2007). The cognitive deﬁcits include do-
mains of executive attention (Orellana et al., 2012), working
memory (Collins et al., 2014), verbal skills (Bozikas et al., 2005),
executive functioning, and speed of processing (Helldin et al.,
2006). A review conducted by Lepage et al. (2014) reported that
these neurocognitive deﬁcits would affect an individual's func-
tional status across different outcome domains (i. e. self-care,Ireland Ltd. This is an open acces
g).independent living, social and interpersonal functioning, voca-
tional functioning etc.) (Lepage et al., 2014).
Mini-Mental State Examination (MMSE) is a brief measure of
global cognition and is often used for evaluation of cognitive
functioning. This instrument was developed by Folstein et al.
(1975) to assess ﬁve domains of cognition: orientation with regard
to time and place, registration of words, attention and calculation,
recall, and language (Folstein et al., 1975). It is a validated and ef-
fective screening tool for cognitive impairment among elderly,
community dwelling, institutionalized, and hospitalized adults
(Tombaugh and McIntyre, 1992).
Studies conducted in different populations found that MMSE
scores were inﬂuenced by socio-demographic factors such as age
and education in Portuguese healthy adults (Santana et al., 2015)
and ethnic differences in Singapore community-living elderly po-
pulation (Ng et al., 2007). Age (Maltais et al., 2015) and level of
education (Moore et al., 2004) were two prominent socio-demo-
graphic factors associated with MMSE in patients with schizo-
phrenia and gender differences were also found in cognitive per-
formance among older adults in Korea (Han et al., 2008). Younger
age and higher education level were found to be associated with
better MMSE scores, whereas females had more cognitives article under the CC BY-NC-ND license
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MMSE scores, followed by age and gender in elderly Koreans (Kim
et al., 2012).
Other factors such as heavy smoking (Razani et al., 2004) and
alcohol consumption (Manning et al., 2009) were also associated
with cognitive impairment assessed using other cognitive tests.
Studies suggest that smoking has a negative inﬂuence on cognition
and the brain (Swan and Lessov-Schlaggar, 2007). Similarly among
alcohol dependent patients, deﬁcits in the visual episodic memory,
slower reaction time, and reduced working memory span have
been reported compared to healthy controls (Kopera et al., 2012).
In terms of clinical factors, age of onset (van der Werf et al.,
2012), length of hospital stay (Kato et al., 1995), type of anti-
psychotic medication (Keefe et al., 1999), and duration of illness
(Talreja et al., 2013) were found to inﬂuence cognitive functioning
in patients with schizophrenia. A meta-analysis conducted by Rajji
et al. (2009) revealed that cognitive deﬁcits differ among patients
based on their age of onset. Individuals with youth-onset schizo-
phrenia have longer duration of illness and thus greater effect of
chronicity than individuals with late-onset schizophrenia (Rajji
et al., 2009). Separately, a study conducted in inpatients found that
cognitive tests which measure memory for nonverbal visual sti-
muli, visual attention, and task switching were the best predictors
of length of hospital stay (Kato et al., 1995). In terms of types of
antipsychotic medications, ﬁrst generation (typical) antipsychotics
(e.g. chlorpromazine and haloperidol) possess detrimental effects
on memory, motor functions, and higher order cognitive functions
(Hill et al., 2010). In contrast to typical antipsychotics, second
generation (atypical) antipsychotics were proposed to be a better
treatment option for patient with schizophrenia wherein they
have lesser side effects and address the cognitive impairments
suffered by the patients (He et al., 2009; Keefe et al., 1999). Con-
ﬂicting ﬁndings have been shown for other clinical factors such as
duration of illness where Hyde et al. (1994) reported age, instead
of duration of illness to be associated with cognitive decline in
Boston Naming test, while Talreja et al. (2013) found signiﬁcant
association between duration of illness and MMSE scores in pa-
tients with schizophrenia.
Throughout the world, there is a shift towards managing and
treating patients with schizophrenia in the community. Dein-
stitutionalisation started in 1970s in California and long-stay care
in psychiatric hospitals has progressively been replaced by com-
munity mental health care in present England, USA, Eastern, and
South-eastern Asian countries (Borsay, 2006; Chong and Sub-
ramaniam, 2014; Finkel et al., 2007; Fisher et al., 2001; Institute of
Mental Health, 2014; Ito et al., 2012; Santana et al., 2015; Scheff,
2014). The reasons for such movement are numerous and complex
and community care is assumed to be more humane, therapeutic,
and cost effective (Chong and Subramaniam, 2014). Considering
the move towards community care, there is a need to examine the
cognitive functioning of patients who have been institutionalized
to ensure that patients are capable of independent living outside
the hospital.
Institute of Mental Health (IMH) is the only tertiary psychiatric
hospital in Singapore providing psychiatric services to the men-
tally ill (Institute of Mental Health, 2014). This institute has about
2000 beds spread over 50 wards, with 24 wards dedicated for
long-stay patients. According to a previous study conducted in
IMH long-stay patients, most patients were in the older age group
i. e. average age of 45.5 years for males and 55.8 years for females;
most had primary school education and comprised 3 major ethnic
groups (Chinese, Malay, and Indian) (Eu et al., 2001). Given this
particular proﬁle, the investigators felt that MMSE would be most
suited for measuring cognitive impairments as it has a short ad-
ministration time of approximately 10–15 mins (Molloy and
Standish, 1997) and it is available in validated English, Chinese, andMalay language version (Feng et al., 2012; Ibrahim et al., 2009;
Tombaugh and McIntyre, 1992). To date, two studies on MMSE
have been conducted in Singapore. In 2007, Ng et al. (2007) uti-
lised MMSE in older adults to identify those with and without
dementia while another study looked at MMSE performance in
Chinese older adults to detect early cognitive impairment (Feng
et al., 2012; Ng et al., 2007). Past studies looking at MMSE are
focused on detecting dementia among Singaporean older adults. In
comparison, few studies have looked at MMSE in long-term in-
stitutionalized patients with schizophrenia in Singapore context.
While previous studies support the association of MMSE with
age and education in patients with schizophrenia, few studies have
examined the association of cognitive impairment with clinical
factors such as age of illness onset (Johnstone et al., 1989; Rajji
et al., 2009), length of hospital stay (Kato et al., 1995), types of
antipsychotic medications (Désaméricq et al., 2014), and duration
of illness (Talreja et al., 2013) in institutionalized long-stay pa-
tients with schizophrenia. The aim of the current study was to
assess how much variance in MMSE scores could be explained by
socio-demographic factors (i.e. age, gender, ethnicity, level of
education, smoking behaviour, and alcohol consumption) and
clinical factors (i.e. age of onset, length of hospital stay, types of
antipsychotic medications, and duration of illness). The study also
examined whether clinical factors (i.e. age of onset, length of
hospital stay, type of antipsychotic medications, and duration of
illness) were able to predict a signiﬁcant amount of variance in
MMSE scores after controlling for the possible confounders due to
socio-demographic factors. Based on the extant literature, we hy-
pothesized that (1) education level will predict the largest amount
of variance; followed by age and gender and that (2) after ad-
justing for socio-demographic factors, youth-onset schizophrenia,
longer length of hospital stay, typical antipsychotic medications,
and longer duration of illness would predict a lower MMSE scores.2. Material and methods
2.1. Participants
A cross-sectional study was conducted to assess the physical health status of
long-stay patients with severe mental illness in a tertiary hospital. Patients were
recruited at the Institute of Mental Health (IMH), Singapore through referrals by
clinicians and nurses based on the study's inclusion criteria. Participants aged 21
years old and above were recruited from the long-stay wards. The criterion for
classifying a patient as long-stay was a minimum duration of one-year hospitali-
sation. All patients were diagnosed by psychiatrists as suffering from schizophrenia
or schizoaffective disorders (107 with schizophrenia and 3 with schizoaffective
disorders), as deﬁned by DSM-IV criteria (American Psychiatric Association, 1994).
Patients, who were able to comprehend and provide written informed consent as
well as take part in the study assessments and those without any impairment in
communication at the point of recruitment, were recruited into the study. Patients
with either dementia or intellectual disability were excluded based on medical case
notes for the psychiatric diagnosis. Ethics approval for the study was given by the
National Healthcare Group Domain Speciﬁc Review Board.
2.2. Socio-demographic characteristics
Due to the small sample size, most variables were re-coded into categorical
variables. Education level was categorized according to the number of years com-
pleted in the Singapore education system, and was divided into three different
education level; low (below primary school; r6 years of education), medium
(secondary school; 7–11 years of education), and high (at least college or uni-
versity; Z12 years of education) (Singapore, 2015). Information on other socio-
demographic characteristics such as gender, ethnicity, marital status, and health
behaviours was also collected. Marital status was categorized as single, married,
and others which included those who were widowed, divorced, and separated.
Health behaviour included smoking behaviour and alcohol consumption. Patients
were categorized as ex-smoker, smoker, and non-smoker based on their self-report.
For alcohol consumption, patients were asked if there was any period in their life
when they drank at least 12 drinks in a year, and response categories were at least
12 drinks a year, less than 12 drinks a year, and never drank alcoholic drinks.
Table 1
Socio-demographic and clinical information of the patients.
Sample (n¼110) n % Mean Standard
error
Characteristics of
study sample
Age, years 55.9 0.9
Gender
Male 94 85.5
Female 16 14.5
Ethnicity
Chinese 88 80.0
Malay 16 14.5
Indian 6 5.5
Marital status
Single 84 76.4
Married 5 4.5
Others a 21 19.1
Education, years 8.1 0.4
Low (r 6 years) 38 34.5
Medium (7–11 years) 55 50.0
High (Z 12 years) 17 15.5
Smoking behaviour
Smoker 7 6.4
Ex-smoker 68 61.8
Non-smoker 35 31.8
Alcohol consumption
At least 12 drinks a year 18 16.4
Less than 12 drinks a year 42 38.2
Never drank alcoholic drinks 50 45.5
Age of onset
Youth-onset schizophrenia
(r19 years old)
20 18.2
Other age of onset (20–39) 75 68.2
Late-onset schizophrenia
(Z40 years old)
14 12.7
Length of hospital stay (years) 8.6 0.7
Type of antipsychotic
medications
Atypical 23 20.9
Typical 44 40.0
Typical and atypical
(combination)
40 36.4
No antipsychotic
medicationsb
3 2.7
Duration of illness (years) 27.0 1.0
a Includes widowed, divorced, and separated.
b Omitted in regression analysis due to small sample size (n¼3).
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Age of onset was checked from medical records and categorized into youth-
onset schizophrenia (r19 years old), late-onset schizophrenia (Z40 years old),
and other age of onset (20–39 years old) (Rajji et al., 2009). Length of hospital stay
was recorded in months and converted to years by calculating from the date of
admission to the ward to the month of administering the study. Patients were
classiﬁed on the basis of type of antipsychotic medications prescribed as those on
typical antipsychotic drugs only, atypical antipsychotic drugs only, combination of
typical and atypical drugs, and those who were not on antipsychotics. Duration of
illness was recorded in months and converted to years based on the age of onset of
illness to the month of administering the study.
2.4. Assessments
The details of the study were explained to all patients. Informed consent was
taken on the ﬁrst visit from all subjects who agreed to participate. In cases where
patients were unable to comprehend English, the consent form was explained to
the respondent in a language understood by him/her, in the presence of a witness.
After consent was taken from the patients, medical history was checked with the
medical case notes for the psychiatric diagnosis, age of onset, length of stay at the
hospital, and types of antipsychotic medications consumed. On the second visit,
patients were interviewed by trained researchers and data on socio-demographic
and health behaviours were collected. Singapore MMSE was administered to all
patients (Feng et al., 2012). For cases where patients were unable to read, language
testing on reading skill which requires participant to read the phrase “Close your
eyes” was not administered to them. Nevertheless, the present study showed that
MMSE score had good internal consistency, with a Cronbach's alpha coefﬁcient of
0.82. The MMSE has a maximum score of 30. Severity of cognitive impairment has
been classiﬁed into three levels: 24–30¼no cognitive impairment, 18–23¼mild
cognitive impairment and 0–17¼severe cognitive impairment. In addition, a paper
by Feng et al. (2012) calculated the sensitivity and speciﬁcity estimates for Singa-
pore MMSE. Accordingly, instead of the traditional cut-off score of 24, three new
cut-off scores of 25, 27, and 29 were selected for subjects with no education, pri-
mary, and secondary school and above education levels respectively. Based on the
participants’ level of education, those scoring less than the new cut-off scores were
determined to have cognitive impairment (Feng et al., 2012). Different language
versions of the MMSE (English, Chinese, and Malay) were used to cater to patients'
language ability, and the language was chosen according to the patient's familiarity
and comfort.
2.5. Statistics
All statistical analysis was performed using the Statistical Package for the Social
Sciences version 23.0. Mean and standard error were calculated for continuous
variables, and frequencies and percentages were calculated for categorical vari-
ables. Using multiple linear regression analysis, socio-demographic factors in-
cluding age, gender, ethnicity, marital status, level of education, smoking behaviour,
and alcohol consumption were entered as independent variables to predict MMSE
score (Table 3, Model 1). In Model 2, only clinical factors including age of onset
(youth-onset schizophrenia, late-onset schizophrenia, and other age of onset),
length of hospital stay, type of antipsychotic medications (excluding those who
were not prescribed any antipsychotic medications, n¼3), and duration of illness
were added as inﬂuencing factors. To test for any independent associations be-
tween each clinical factors and MMSE scores, multivariate analyses were run using
hierarchical regression where age of onset, length of hospital stay, type of anti-
psychotic medications, and duration of illness were treated as main predictor of
MMSE scores and adjusted for socio-demographic factors. All models were per-
formed by multivariate linear regression using enter method. All statistical sig-
niﬁcant differences were set a po0.05.3. Results
Table 1 shows the socio-demographic and clinical information
of the patients. The sample consisted of 110 patients (88 Chinese,
16 Malay, and 6 Indian) with more men (85.5%) than women
(14.5%). Out of 110 patients recruited, 59 patients completed
MMSE in English; 42 completed in Chinese; and 9 completed it in
Malay. The age range was 25–90 with a mean age of 55.9 (SE¼0.9)
years. In terms of education, majority (50.0%) fell under the
medium education level (7–11 years) while the rest were in low
(r6 years; 34.5%) and high (Z12 years; 15.5%) categories. There
were a total of 20 patients (18.2%) with youth-onset schizophrenia,
75 patients (68.2%) with other age of onset, and 14 patients (12.7%)with late-onset schizophrenia. Patients’ length of hospital stay
ranged from 1.0 to 28.9 years, averaging 8.6 years (SE¼0.7).
Table 2 shows the number of participants who have cognitive
impairment based on the severity method and education-cor-
rected cut-off score. The minimum and maximum MMSE score
achieved by patients were 11 and 30 respectively and the mean
score was 22.2 with a standard deviation of 4.6. According to the
severity method of scoring for MMSE, 51 (46.4%) showed no cog-
nitive impairment (scoring above 24), 39 (35.5%) showed mild
cognitive impairment (below 24 but above 18), and 20 (18.2%)
showed severe cognitive impairment (scoring below 18). However,
based on the education-corrected cut-off method of scoring, 92
(83.6%) patients showed presence of cognitive impairment (Ta-
ble 2) (Feng et al., 2012). Haloperidol (21.8%), risperidone (20.9%),
and olanzapine (18.2%) were the three most common anti-
psychotic medications consumed by participants. 23 (20.9%) were
on atypical antipsychotic medications only, 44 (40.0%) on typical
antipsychotic medications only, 40 (36.4%) were receiving a com-
bination of atypical and typical antipsychotic medications, while 3
(2.7%) were not on any antipsychotic medication. Duration of ill-
ness ranged from 14.1 to 69.8 years, averaging 27.0 years (SE¼1.0).
Table 2
Cognitive impairment according to MMSE scale in patients with schizophrenia or
schizoaffective disorders.
Method Score Interpretation n % na %a Mean Standard
deviation
Severity 24–30 No cognitive impairment 51 46.4 18 16.4 22.2 4.6
18–23 Mild cognitive impairment 39 35.5
92 83.60–17 Severe cognitive impairment 20 18.2
Total 110 100 110 100
a Based on education-corrected MMSE cut-off scores. Education-corrected cut-
off classiﬁcation was based on highest education level attained by participant
where cognitive impairment was labelled for those who scored less than 25 with
no education, less than 27 with primary education, and less than 29 with secondary
and above education Feng et al. (2012).
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the variance in the MMSE score (Adjusted R2¼14.9%; F (12, 94)¼
2.547, p¼0.006; Table 3, Model 1). The overall model was statis-
tically signiﬁcant where the MMSE score was signiﬁcantly lower
among older patients (β¼0.11, 95% CI, 0.20, 0.01, p¼0.024),
signiﬁcantly higher among females (β¼3.22, 95% CI, 0.41, 6.03,
p¼0.025), and those with high education level [vs. low education
level] (β¼3.44, 95% CI, 0.71, 6.17, p¼0.014).
The association of clinical factors and MMSE scores are shown
in Table 3, Model 2. The overall model was signiﬁcant (Adjusted
R2¼17.0%, F (6, 97)¼4.526, po0.001). The MMSE score was sig-
niﬁcantly higher among patients with other age of onset [vs.
youth-onset schizophrenia] (β¼2.53, 95% CI, 0.37, 4.70, p¼0.022)
and signiﬁcantly lower with increasing length of hospital stay
(β¼0.16, 95% CI, 0.28, 0.04, p¼0.010).
Further analysis was conducted to assess whether age of onset
and length of hospital stay remained signiﬁcant in predicting
amount of the variance in MMSE score after adjusting for the
possible effect of socio-demographic factors. Results of the hier-
archical multiple regression partially supported our research hy-
pothesis (Table 3, Model 3). Age of onset was borderline signiﬁcant
(p¼0.051) while length of hospital stay remained signiﬁcant in
predicting MMSE score (β¼0.14, 95% CI, 0.27, 0.01,
p¼0.035). The best model for predicting MMSE score was the
combination of socio-demographic and clinical factors (Adjusted
R2¼22.5%, F (18, 85)¼2.659, p¼0.001). Addition of age at onset,
length of hospital stays, type of antipsychotic medication, and
duration of illness into the ﬁrst model, which included only the
socio-demographic factors, signiﬁcantly improved prediction (R2
change¼12.3%, F change¼2.718, p¼0.018).4. Discussion
In a sample of 110 inpatients with schizophrenia or schi-
zoaffective disorders, this study examined the cognitive impair-
ment and predictive role of socio-demographic and clinical factors
in cognitive functioning measured using MMSE. Our results
showed support for our ﬁrst hypothesis where education level
predicted the largest amount of variance; followed by age and
gender (Kim et al., 2012) (Table 3 model 1) and partial support for
our second hypothesis where after adjusting for socio-demo-
graphic factors, only length of hospital stay was associated with
MMSE scores (Table 3 model 3).
In terms of institutionalised patients with schizophrenia, stu-
dies have been conducted on similar populations. Harvey et al.
(1997) conducted a study in New York and London and found si-
milar cognitive impairment in long-stay patients with schizo-
phrenia measured using MMSE (Harvey et al., 1997). Furthermore,
a study by Diaz et al. (2011) looked into the cognitive performanceof long-term institutionalized elderly patients with schizophrenia
in Brazil and compared them with institutionalized patients
without neurological or psychiatric diseases, matched for age,
educational level and institutionalization time. They found worse
performance in Cambridge Cognition Examination (CAMCOG)
score in institutionalized patients with schizophrenia than among
patients without neurological or psychiatric diseases. Lower scores
were also reported in MMSE (Diaz et al., 2011).
Our ﬁndings also lend support to previous studies which found
an association of age and education on MMSE scores. In Table 3
model 1, our study showed associations between age, gender, and
education with MMSE scores. In a study conducted with adult
participants across all ages, MMSE scores declined with age even
after controlling for variables such as education (Crum et al., 1993).
MMSE test measures ﬁve different cognitive domains which in-
cludes orientation and recall. The processing speed theory of
cognitive aging suggests that as individuals grow older, the pro-
cessing speed in memory and spatial ability would be affected and
thus cognitive performance would decline (Finkel et al., 2007).
Also, it is worth noting that as age increases, it is associated with
increasing risk of dementia which would therefore inﬂuence the
cognitive performance (World Health Organization [WHO], 2014).
Despite the risk of dementia increasing with age, a 6 years long-
itudinal study by Friedman et al. (2001) found different rates of
cognitive decline in institutionalized elderly patients with schi-
zophrenia and patients with Alzheimer disease. Greater rate of
cognitive decline were found in long-term institutionalized elderly
patients with schizophrenia than patients with Alzheimer disease
(Friedman et al., 2001).
A recent study conducted by Feng et al. (2012) found positive
relationship between the level of education and cognitive perfor-
mance in Singapore community-dwelling older adults (Feng et al.,
2012). Also, in a study conducted in Brazilian sample of 73 elderly
institutionalized patients with schizophrenia, there was a sig-
niﬁcant association between the years of education with MMSE
performance. Findings in this study reported that even a low level
of formal education has a profound impact on late-life cognition in
institutionalized patients with schizophrenia (Vega et al., 2005).
In addition to age and education, gender was also signiﬁcantly
associated with MMSE scores. Some studies reported little to no
signiﬁcant relationship between gender and MMSE scores. Tom-
baugh and McIntyre (1992) did not ﬁnd signiﬁcant differences in
MMSE scores between males and females (Tombaugh and McIn-
tyre, 1992). However, other studies saw gender differences in
cognitive performance in speciﬁc domains (Gallo and Jones, 2002;
Royer et al., 1999). In a study conducted using MMSE in commu-
nity-dwelling adults, females were found to perform slightly faster
than males on verbal-processing tasks but made mistakes on serial
subtractions (Gallo and Jones, 2002). Possible reason of the gender
difference in cognitive performance could be due to brain-derived
neurotrophic factor (BDNF). BDNF is a brain protein that may be
involved in the pathophysiology of schizophrenia and a study
found different level of BDNF between genders in patients with
chronic schizophrenia (Zhang et al., 2014).
In the ﬁnal model (Table 3, Model 3), no signiﬁcant association
was found between age, gender, and education after controlling
for clinical factors. Possible underlying mechanism could be due to
other factors such as severity of illness and dosage of medication
load which may contribute for a larger portion of cognitive decline
in patients with schizophrenia (Maltais et al., 2015).
Our study failed to demonstrate any inﬂuence of alcohol con-
sumption on MMSE results which is in contrast with existing lit-
erature on inpatients with dual diagnosis of schizophrenia and
alcohol use disorder (Manning et al., 2009). Possible reasons could
be due to the care and conditions in the wards where alcohol
consumption is strictly prohibited in patients. These patients are
Table 3
Unstandardized beta coefﬁcient estimates (95% Conﬁdence Interval) representing the hierarchical regression analysis of MMSE scores on clinical factors adjusted for socio-
demographic factors.
Model 1 (Adj R2a¼14.9%) Model 2 (Adj R2a¼17.0%) Model 3 (Adj R2a¼22.5%)
Beta 95% CIc p Beta 95% CIc p Beta 95% CIc p
Characteristics of study sample
Age, years 0.11 0.20, 0.01 0.024 0.06 0.16, 0.04 0.207
Gender (Female) 3.22 0.41, 6.03 0.025 2.65 0.13, 5.44 0.062
Ethnicity
Malay vs. Chinese 0.01 2.52, 2.49 0.991 0.18 2.60, 2.24 0.883
Indian vs. Chinese 0.73 4.64, 3.18 0.713 1.35 5.16, 2.45 0.482
Marital status
Single vs. married 1.08 3.08, 5.23 0.608 1.62 2.36, 5.59 0.422
Othersb vs. married 1.31 5.84, 3.21 0.566 0.90 5.25, 3.46 0.684
Level of Education
Medium vs. low 0.47 1.44, 2.37 0.629 0.73 1.15, 2.61 0.441
High vs. low 3.44 0.71, 6.17 0.014 2.48 0.28, 5.24 0.077
Smoking behaviour
Ex-smoker vs. non-smoker 1.40 0.82, 3.63 0.214 0.86 1.46, 3.18 0.464
Smoker vs. non-smoker 0.39 3.68, 4.46 0.850 0.61 4.64, 3.42 0.765
Alcohol consumption
More than 12 drinks a year vs. never drank 2.23 0.49, 4.97 0.107 2.14 0.47, 4.76 0.107
Less than 12 drinks a year vs. never drank 0.38 2.31, 1.56 0.702 0.29 2.24, 1.66 0.769
Age of onset
Other age of onset vs. youth-onset schizophrenia 2.53 0.37, 4.70 0.022 2.36 0.01, 4.74 0.051
Late-onset schizophrenia vs. youth-onset schizophrenia 1.32 4.67, 2.03 0.437 0.74 4.28, 2.81 0.681
Length of hospital stay, years 0.16 0.28, 0.04 0.010 0.14 0.27, 0.01 0.035
Type of antipsychotic medications
Typical vs. atypical 1.71 3.86, 0.45 0.119 1.31 3.48, 0.85 0.232
Typical and atypical vs. atypical 0.30 1.86, 2.46 0.781 0.48 2.69, 1.73 0.664
Duration of illness, years 0.01 0.09, 0.11 0.865 0.04 0.06, 0.13 0.457
Notes: n¼107 were used for regression analysis.
a Adj R2¼Adjusted R2.
b Includes widowed, divorced, and separated.
c CI¼conﬁdence interval.
H.L. Ong et al. / Psychiatry Research 241 (2016) 256–262260regularly monitored for physical illness with their diet being su-
pervised and exercises planned for them. Secondly, compared to
the literature, the patients in our sample were not diagnosed with
alcohol use disorder and thus were not inﬂuenced by the side-
effect of heavy drinking on cognition. Lastly, the consumption of
alcohol was measured by self report in our study. Patients may
have reported their drinking habits from before they were ad-
mitted as inpatients and, thus, their responses recorded may not
be an accurate reﬂection of their actual consumption behaviour.
Our ﬁndings lend support to previous studies which found an
association of length of hospital stay with MMSE score. Length of
hospital stay remained signiﬁcant in predicting MMSE scores even
after adjusting for socio-demographic and other clinical factors.
Similar to our ﬁndings, other studies did not ﬁnd signiﬁcant as-
sociations between typical antipsychotic drugs or atypical anti-
psychotic drugs on cognitive functioning in patients (Nielsen et al.,
2015). Furthermore, other studies did not look into the in-
dependent association between age of onset with cognitive deﬁ-
cits (Rajji et al., 2009) and duration of illness with MMSE scores
after adjusting for socio-demographic factors (Talreja et al., 2013).
Possible underlying mechanisms have been proposed for the
inverse relationship between length of hospital stay with MMSE.
Length of hospital stay may determine the severity of cognitive
impairment in inpatients where patients who have longer stay in
hospital tend to have severe psychotic symptoms and thus greater
cognitive impairment than those who have shorter stay. Institu-
tional settings are more likely to induce passiveness than com-
munity settings (Goffman, 1961; Wing and Brown, 1970). Com-
pared to patients who resided in the community centres, patients
residing in psychiatric hospital have a signiﬁcantly lower score on
the Life Skills Proﬁle (LSP), indicating higher disability (Eu et al.,
2001). Conversely, it is possible that cognitive impairment mayworsen the condition of psychiatric patients, and result in longer
periods of hospitalizations (Kato et al., 1995).
Several limitations in our study deserve consideration. Firstly,
the sample size was small. There were more males than females,
fewer Indians, and married subjects which limited meaningful
comparisons between these groups. Secondly, there might be a
selection bias in our study. The group was selected based on
whether they were able to comprehend and provide written in-
formed consent as well as included only those without any im-
pairment in communication. This might exclude those with severe
symptoms, obvious cognitive and language dysfunctions in the
study. Including these patients would have enabled us to study in
a wider perspective those who are most affected by the psychiatric
illness and thus further studies could look into this area of re-
search. Thirdly, we did not employ scales measuring psycho-
pathology such as the Positive and Negative Syndrome Scale
(PANSS) or Clinical Global Impression – Schizophrenia (CGI-SCH)
scale that measure patients' psychopathology objectively and this
can be a confounder of the study (Haro et al., 2003; Kay et al.,
1987). Finally, MMSE consists of questions that involve patients to
give verbal responses and reading. Therefore, patients who were
visually and hearing impaired or with communication disorders
may perform poorly even when cognitively able. To reduce the
likelihood of such occurrence, magnifying glass and Williams
Sound Pocketalkers Ultra System H021 were provided for simple
magniﬁcation of text and sound.
Despite these limitations, our study draws attention to the
signiﬁcance of length of hospital stay on cognitive performance
measured by MMSE in long-stay patients diagnosed with schizo-
phrenia or schizoaffective disorders in Singapore. The recruitment
of patients was through referral from the clinicians or nurses who
deemed these patients to be suitable to be interviewed. Arguably,
H.L. Ong et al. / Psychiatry Research 241 (2016) 256–262 261the study sample would be at the highest probability of being
discharged by the hospital yet the results of the current study
indicate that 92 out of 110 patients (83.6%) have presence of
cognitive impairment based on the education-corrected method of
scoring. While it is better that patients are reintegrated back into
the society, service providers should not overlook the cognitive
ability of patients while considering deinstitutionalisation.
Both physical and mental exercises should be considered for
people with schizophrenia. At the Institute of Mental Health
(Singapore), care and conditions should be continued and main-
tained. All patients in the hospital are strictly prohibited from
smoking and alcohol consumption in the wards, regularly mon-
itored for physical illness, and diet is supervised with exercise
programs planned and incorporated into their daily routine. Stu-
dies reported that structured exercise especially aerobic exercises
have various beneﬁts including improvement in cognitive ability
of the patients including reduction of risk for cerebrovascular and
cardiovascular disease (Guimarães et al., 2015; Ratey and Loehr,
2011; University of California - Los Angeles, 2016). Mental ex-
ercises such as computerised tasks training, performing tasks re-
petitively, and using new strategies for learning were found to be
effective in treating cognitive deﬁcits in patients with schizo-
phrenia (Bowie and Harvey, 2006). Although these training pro-
grams can be expensive and labour intensive, these could improve
patients’ cognition. Cognitive impairments can be used as a pre-
dictive tool for the functional ability outcome in schizophrenia
(Addington and Barbato, 2012). Together with self-motivation and
insight, functional ability is an important determinant of recovery
(Walters and Agius, 2014).
In conclusion, the present study demonstrated that socio-de-
mographic factors (i.e. age, gender, and level of education) and
clinical factors (i. e. age of onset, and length of hospital stay) were
associated with cognition, measured by MMSE – a brief measure of
global cognition. Length of hospital stay remained signiﬁcant in
predicting MMSE scores after controlling for socio-demographic
factors. Early introduction and sustained delivery of a combination
of physical and mental exercises should be considered to improve
the cognitive functioning of patients with schizophrenia or schi-
zoaffective disorder.Funding sources
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